Skip to main content
Top
Published in: Pediatric Nephrology 10/2014

01-10-2014 | Original Article

Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease

Authors: Antony Aston, Rebecca Cardigan, Saber Bashir, Susan Proffitt, Helen New, Colin Brown, Ri Liesner, Sylvia Hennem, Helen Nulty, Olivia Shaw, Robert Vaughan, Jon Jin Kim, Lesley Rees

Published in: Pediatric Nephrology | Issue 10/2014

Login to get access

Abstract

Background

Standard leucodepleted blood transfusions can induce the production of human leukocyte antigen (HLA)-specific antibodies, which are associated with longer transplant waiting times and poorer graft outcomes. We hypothesized that additional washing of leucodepleted red cells might reduce antigenic stimulus by removal of residual leukocytes and soluble HLA.

Methods

A retrospective review of HLA antibodies in children with chronic kidney disease stage 4–5 who had ≥two HLA antibody screens between 2000 and 2009, pre- and post-transfusion, and were HLA antibody-negative at first testing. Patients were divided according to whether they received standard leucodepleted blood or “washed cells”. To assess the efficacy of washing methods, total leukocytes were enumerated pre- and post- manual and automated washing of standard leucodepleted red cells that had been supplemented with whole blood to achieve measurable leukocyte levels pre-washing.

Results

A total of 106 children were included: 23 received no blood transfusions (group 1), six had washed cells only (group 2), 59 had standard transfusions only (group 3), and 18 had both standard and washed cells (group 4). Sensitization rates were 26, 17, 44, and 44 % in groups 1–4 (p = 0.32). Patients in groups 3 and 4 had more transfusions with red cells, platelets, and plasma products. There was no difference in HLA sensitization risk with washed or standard red cells on analysis of co-variance controlling for platelets and plasma transfusions. The red cell washing study showed no significant reduction in leukocytes using manual methods. Although there was a statistically significant reduction (33 %) from baseline pre-washing using the automated method, from 6.54 ± 0.84 × 106 to 4.36 ± 0.67 × 106 leukocytes per unit, the majority of leukocytes still remained.

Conclusions

There was no evidence that using washed leucodepleted red cells reduced patient HLA sensitization rates. Washing leucodepleted red cells is unlikely to reduce the risk of HLA sensitization due to the limited effect on residual leukocytes.
Literature
1.
go back to reference Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, Rossert J, Chertow GM, Tyan DB (2013) Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrol Dial Transplant. doi:10.1093/ndt/gft362 PubMed Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, Rossert J, Chertow GM, Tyan DB (2013) Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrol Dial Transplant. doi:10.​1093/​ndt/​gft362 PubMed
3.
go back to reference Scornik JC, Meier-Kriesche HU (2011) Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant 11:1785–1791PubMedCrossRef Scornik JC, Meier-Kriesche HU (2011) Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant 11:1785–1791PubMedCrossRef
4.
go back to reference Scornik JC, Pfaff WW, Howard RJ, Fennell RS 3rd, Ramos E, Peterson JC, Neiberger R (1994) Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 58:1361–1365PubMed Scornik JC, Pfaff WW, Howard RJ, Fennell RS 3rd, Ramos E, Peterson JC, Neiberger R (1994) Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 58:1361–1365PubMed
5.
go back to reference Vella JP, O'Neill D, Atkins N, Donohoe JF, Walshe JJ (1998) Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplant 13:2027–2032PubMedCrossRef Vella JP, O'Neill D, Atkins N, Donohoe JF, Walshe JJ (1998) Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplant 13:2027–2032PubMedCrossRef
6.
go back to reference Obrador GT, Macdougall IC (2013) Effect of red cell transfusions on future kidney transplantation. Clin Am Soc Nephrol 8:852–860CrossRef Obrador GT, Macdougall IC (2013) Effect of red cell transfusions on future kidney transplantation. Clin Am Soc Nephrol 8:852–860CrossRef
7.
go back to reference Gombos P, Opelz G, Scherer S, Morath C, Zeier M, Schemmer P, Susal C (2013) Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant 13:2075–2082PubMedCrossRef Gombos P, Opelz G, Scherer S, Morath C, Zeier M, Schemmer P, Susal C (2013) Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant 13:2075–2082PubMedCrossRef
8.
go back to reference Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE (2004) Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 103:333–339PubMedCrossRef Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE (2004) Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 103:333–339PubMedCrossRef
9.
go back to reference McPherson ME, Anderson AR, Castillejo MI, Hillyer CD, Bray RA, Gebel HM, Josephson CD (2010) HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 54:552–558PubMedPubMedCentral McPherson ME, Anderson AR, Castillejo MI, Hillyer CD, Bray RA, Gebel HM, Josephson CD (2010) HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 54:552–558PubMedPubMedCentral
10.
go back to reference Karpinski M, Pochinco D, Dembinski I, Laidlaw W, Zacharias J, Nickerson P (2004) Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J Am Soc Nephrol 15:818–824PubMedCrossRef Karpinski M, Pochinco D, Dembinski I, Laidlaw W, Zacharias J, Nickerson P (2004) Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J Am Soc Nephrol 15:818–824PubMedCrossRef
11.
go back to reference van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A (2003) HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 43:765–771PubMedCrossRef van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A (2003) HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 43:765–771PubMedCrossRef
12.
go back to reference Sparrow RL, Patton KA (2004) Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 44:722–730PubMedCrossRef Sparrow RL, Patton KA (2004) Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 44:722–730PubMedCrossRef
13.
go back to reference Mancini R, Marinelli L, Mirante N, Gallo A, Matteocci A, Terlizzi F, Palange M, Fioravanti D, Donnini L, Pierelli L (2012) Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with beta-thalassaemia. Blood Transfus 10:39–44PubMedPubMedCentral Mancini R, Marinelli L, Mirante N, Gallo A, Matteocci A, Terlizzi F, Palange M, Fioravanti D, Donnini L, Pierelli L (2012) Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with beta-thalassaemia. Blood Transfus 10:39–44PubMedPubMedCentral
14.
go back to reference Hiesse C, Busson M, Buisson C, Farahmand H, Bierling P, Benbunan M, Bedrossian J, Aubert P, Glotz D, Loirat C, Rondeau E, Viron B, Bleux H, Lang P (2001) Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation. Kidney Int 60:341–349PubMedCrossRef Hiesse C, Busson M, Buisson C, Farahmand H, Bierling P, Benbunan M, Bedrossian J, Aubert P, Glotz D, Loirat C, Rondeau E, Viron B, Bleux H, Lang P (2001) Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation. Kidney Int 60:341–349PubMedCrossRef
15.
go back to reference Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hene RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ (2009) Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Nephrol Dial Transplant 24:2559–2566PubMedCrossRef Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hene RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ (2009) Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Nephrol Dial Transplant 24:2559–2566PubMedCrossRef
16.
go back to reference Balasubramaniam GS, Morris M, Gupta A, Mesa IR, Thuraisingham R, Ashman N (2012) Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion. Transplantation 93:418–422PubMedCrossRef Balasubramaniam GS, Morris M, Gupta A, Mesa IR, Thuraisingham R, Ashman N (2012) Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion. Transplantation 93:418–422PubMedCrossRef
17.
go back to reference Pfaff WW, Howard RJ, Scornik JC, Day C, Renderer J, Scott J, Fennel RS, Peterson JC, Salomon DR, Patton PR (1989) Incidental and purposeful random donor blood transfusion. Sensitization and transplantation. Transplantation 47:130–133PubMedCrossRef Pfaff WW, Howard RJ, Scornik JC, Day C, Renderer J, Scott J, Fennel RS, Peterson JC, Salomon DR, Patton PR (1989) Incidental and purposeful random donor blood transfusion. Sensitization and transplantation. Transplantation 47:130–133PubMedCrossRef
18.
go back to reference Karahan GE, Kekik C, Oguz FS, Onal AE, Bakkaloglu H, Caliskan YK, Yazici H, Turkmen A, Aydin AE, Sever MS, Eldegez U, Carin MN (2010) Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status. Ren Fail 32:380–383PubMedCrossRef Karahan GE, Kekik C, Oguz FS, Onal AE, Bakkaloglu H, Caliskan YK, Yazici H, Turkmen A, Aydin AE, Sever MS, Eldegez U, Carin MN (2010) Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status. Ren Fail 32:380–383PubMedCrossRef
19.
go back to reference Hirata AA, McIntire FC, Terasaki PI, Mittal KK (1973) Cross-reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation 15:441–445PubMedCrossRef Hirata AA, McIntire FC, Terasaki PI, Mittal KK (1973) Cross-reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation 15:441–445PubMedCrossRef
20.
go back to reference El Aggan HA, Sidkey F, El Gezery DA, Ghoneim E (2004) Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity. Egypt J Immunol 11:71–79PubMed El Aggan HA, Sidkey F, El Gezery DA, Ghoneim E (2004) Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity. Egypt J Immunol 11:71–79PubMed
21.
go back to reference Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C, Martin PY, Siegrist CA, Villard J (2011) De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 11:1727–1733PubMedCrossRef Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C, Martin PY, Siegrist CA, Villard J (2011) De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 11:1727–1733PubMedCrossRef
22.
go back to reference Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J (2008) "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 86:1111–1115PubMedCrossRef Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J (2008) "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 86:1111–1115PubMedCrossRef
23.
go back to reference El-Awar N, Terasaki PI, Nguyen A, Sasaki N, Morales-Buenrostro LE, Saji H, Maruya E, Poli F (2009) Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 70:844–853PubMedCrossRef El-Awar N, Terasaki PI, Nguyen A, Sasaki N, Morales-Buenrostro LE, Saji H, Maruya E, Poli F (2009) Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 70:844–853PubMedCrossRef
24.
go back to reference Pereira S, Perkins S, Lee JH, Shumway W, LeFor W, Lopez-Cepero M, Wong C, Connolly A, Tan JC, Grumet FC (2011) Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Hum Immunol 72:492–498PubMedCrossRef Pereira S, Perkins S, Lee JH, Shumway W, LeFor W, Lopez-Cepero M, Wong C, Connolly A, Tan JC, Grumet FC (2011) Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Hum Immunol 72:492–498PubMedCrossRef
25.
go back to reference Poli F, Benazzi E, Innocente A, Nocco A, Cagni N, Gianatti A, Fiocchi R, Scalamogna M (2011) Heart transplantation with donor-specific antibodies directed toward denatured HLA-A*02:01: a case report. Hum Immunol 72:1045–1048PubMedCrossRef Poli F, Benazzi E, Innocente A, Nocco A, Cagni N, Gianatti A, Fiocchi R, Scalamogna M (2011) Heart transplantation with donor-specific antibodies directed toward denatured HLA-A*02:01: a case report. Hum Immunol 72:1045–1048PubMedCrossRef
26.
go back to reference Ishibashi N, Ohto H, Ujiie N, Ariga H, Ishii T, Suzuki H (2003) Low frequency of observed anti-HLA among transfused preterm infants. Transfusion 43:663–667PubMedCrossRef Ishibashi N, Ohto H, Ujiie N, Ariga H, Ishii T, Suzuki H (2003) Low frequency of observed anti-HLA among transfused preterm infants. Transfusion 43:663–667PubMedCrossRef
Metadata
Title
Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease
Authors
Antony Aston
Rebecca Cardigan
Saber Bashir
Susan Proffitt
Helen New
Colin Brown
Ri Liesner
Sylvia Hennem
Helen Nulty
Olivia Shaw
Robert Vaughan
Jon Jin Kim
Lesley Rees
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 10/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-014-2823-6

Other articles of this Issue 10/2014

Pediatric Nephrology 10/2014 Go to the issue